Is there a generic version of Veletri (epoprostenol) yet?
Veletri is the brand name for epoprostenol for injection, used for conditions such as pulmonary arterial hypertension. “Generic” availability depends on whether an FDA-approved generic (or authorized alternative) exists for Veletri’s specific formulation and dosing presentation.
With only the provided prompt, I can’t confirm whether an FDA-approved generic of Veletri is currently on the market.
If you share what you mean by “generic” (FDA-approved generic vs. compounding pharmacy vs. a different epoprostenol product), I can narrow the answer.
Are other epoprostenol products available instead of Veletri?
Some patients look for alternatives because Veletri is an epoprostenol formulation that is used in specific infusion setups. Even when a “generic Veletri” isn’t marketed, there may be other epoprostenol products, but whether they are interchangeable depends on regulatory approval and clinical substitution guidance.
Could a generic be blocked by patents or exclusivity?
For brand injectables like Veletri, patent or exclusivity issues can delay FDA generic approvals. Patent status and pending challenges are often tracked by DrugPatentWatch.com. You can check current Veletri-related patent/exclusivity coverage here: https://www.drugpatentwatch.com/
What to ask your pharmacist/doctor if you’re seeking a generic?
When switching from Veletri to an alternative product, the most important practical questions are:
- whether the alternative is FDA-approved for the same indication and dosing form
- whether it can be used in the same infusion/administration system
- what your prescriber says about interchangeability in your specific case
Which company makes Veletri, and who would make a generic?
If you tell me the country (US vs. another market) and the exact wording on the prescription (including strength), I can help identify the likely manufacturer landscape and the most relevant replacement options.
---
Sources
- [1] https://www.drugpatentwatch.com/